Exchange: OTC·Updated 01:51 PM EDT

IMVIQIMV Inc

$0.00
$0.00
(0.00%)
Today
Reported EarningsMay 27
Vol1,000.00

About

IMV, Inc. is a clinical-stage biopharmaceutical company, which engage in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. Its immune-educating technology includes DPX which is designed to inform a specific, coordinated, and persistent anti-tumor immune response. The company was founded on May 18, 2007 and is headquartered in Dartmouth, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is the 52-week high for IMV Inc?

Advertisement|Remove ads.